Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease-Reference-Cited by-同舟云学术

Effects of levodopa therapy on global left ventricular systolic function in patients with Parkinson disease

Published:2016-06-24 Issue:13-14 Volume:128 Page:528-533
ISSN:0043-5325
Container-title:Wiener klinische Wochenschrift
language:en
Short-container-title:Wien Klin Wochenschr

Author:

Günaydın Zeki Yüksel,Bektaş Osman,Karagöz Ahmet,Özer Fahriye Feriha

Publisher

Springer Science and Business Media LLC

Subject

General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00508-016-1026-5.pdf

Reference33 articles.

1. LeWitt PA. Therapy with dopaminergic drugs in Parkinson’s disease. In: Koller WC, editor. Handbook of Parkinson’s disease. New York: Marcel Dekker; 1992. pp. 469–507.

2. Marsden CD. Parkinson’s disease. Lancet. 1990;335(8695): 948–52.

3. Ahlskog JE. Parkinson’s disease: is the initial treatment established? Curr Neurol Neurosci Rep. 2003;3(4):289–95.

4. Fahn S. A new look at levodopa based on the ELLDOPA study. J Neural Transm Suppl. 2006;70:419–26.

5. Di Stefano A, Sozio P, Cerasa LS, Iannitelli A. L‑Dopa prodrugs: an overview of trends for improving Parkinson’s disease treatment. Curr Pharm Des. 2011;17(32):3482–93.

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Adverse effects of medications used to treat motor symptoms of Parkinson's disease: A narrative review;Annals of Movement Disorders;2023-05

2. Parkinson’s Disease and the Cardiac Cycle: A Rapid Literature Review and Case Series;Life;2023-04-13

3. The potential role of 2D-speckle tracking echocardiography for detecting left ventricular systolic dysfunction in patients with Parkinson’s disease: a case control study;Acta Cardiologica;2020-12-14

4. Evaluation of the effect of non-ergot dopamine agonists on left ventricular systolic function with speckle tracking echocardiography;The Anatolian Journal of Cardiology;2018